BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35142403)

  • 1. Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF-κB, JAK/STAT, and MAPK signaling pathways.
    Haftcheshmeh SM; Abedi M; Mashayekhi K; Mousavi MJ; Navashenaq JG; Mohammadi A; Momtazi-Borojeni AA
    Phytother Res; 2022 Mar; 36(3):1216-1230. PubMed ID: 35142403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling.
    Li W; Yin N; Tao W; Wang Q; Fan H; Wang Z
    Int Immunopharmacol; 2019 Jan; 66():82-90. PubMed ID: 30445310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine inhibits lipopolysaccharide-induced expression of inflammatory cytokines by suppressing TLR4-mediated NF-ĸB and MAPK signaling pathways in rumen epithelial cells of Holstein calves.
    Zhao C; Wang Y; Yuan X; Sun G; Shen B; Xu F; Fan G; Jin M; Li X; Liu G
    J Dairy Res; 2019 May; 86(2):171-176. PubMed ID: 31142385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine hydrochloride protects against cytokine-induced inflammation through multiple pathways in undifferentiated C2C12 myoblast cells.
    Poudel A; Zhou JY; Mekala N; Welchko R; Rosca MG; Li L
    Can J Physiol Pharmacol; 2019 Aug; 97(8):699-707. PubMed ID: 31026403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo.
    Li CL; Tan LH; Wang YF; Luo CD; Chen HB; Lu Q; Li YC; Yang XB; Chen JN; Liu YH; Xie JH; Su ZR
    Phytomedicine; 2019 Jan; 52():272-283. PubMed ID: 30599908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways.
    Tan L; Wang Y; Ai G; Luo C; Chen H; Li C; Zeng H; Xie J; Chen J; Su Z
    Int Immunopharmacol; 2019 Oct; 75():105802. PubMed ID: 31401380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory activity of coptisine free base in mice through inhibition of NF-κB and MAPK signaling pathways.
    Chen HB; Luo CD; Liang JL; Zhang ZB; Lin GS; Wu JZ; Li CL; Tan LH; Yang XB; Su ZR; Xie JH; Zeng HF
    Eur J Pharmacol; 2017 Sep; 811():222-231. PubMed ID: 28648405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
    Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
    Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
    Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of Keap1/Nrf2, P
    Hassanein EHM; Shalkami AS; Khalaf MM; Mohamed WR; Hemeida RAM
    Biomed Pharmacother; 2019 Jan; 109():47-56. PubMed ID: 30396091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine improves airway inflammation and inhibits NF-κB signaling pathway in an ovalbumin-induced rat model of asthma.
    Li Z; Zheng J; Zhang N; Li C
    J Asthma; 2016 Dec; 53(10):999-1005. PubMed ID: 27175622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine, A Phytoalkaloid, Inhibits Inflammatory Response Induced by LPS through NF-Kappaβ Pathway: Possible Involvement of the IKKα.
    Reddi KK; Li H; Li W; Tetali SD
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy.
    Zhu C; Li K; Peng XX; Yao TJ; Wang ZY; Hu P; Cai D; Liu HY
    Front Immunol; 2022; 13():1083788. PubMed ID: 36561763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine-mediated up-regulation of surfactant protein D facilitates cartilage repair by modulating immune responses via the inhibition of TLR4/NF-ĸB signaling.
    Zhou Y; Ming J; Deng M; Li Y; Li B; Li J; Ma Y; Chen Z; Liu S
    Pharmacol Res; 2020 May; 155():104690. PubMed ID: 32057894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine as a promising natural compound for the treatment of periodontal disease: A focus on anti-inflammatory properties.
    Mohammadian Haftcheshmeh S; Momtazi-Borojeni AA
    J Cell Mol Med; 2021 Dec; 25(24):11333-11337. PubMed ID: 34719112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-κB and AMPK signaling pathways.
    Pei C; Zhang Y; Wang P; Zhang B; Fang L; Liu B; Meng S
    Phytother Res; 2019 Feb; 33(2):294-308. PubMed ID: 30402951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine combined with cyclosporine A alleviates acute graft-versus-host disease in murine models.
    Wang M; Zhang J; Zhao H; Wan D; Jiang Z
    Int Immunopharmacol; 2020 Apr; 81():106205. PubMed ID: 32050154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of the nutraceutical bioactive compound berberine in lectin-like OxLDL receptor 1-mediated endothelial dysfunction in comparison to lovastatin.
    Caliceti C; Rizzo P; Ferrari R; Fortini F; Aquila G; Leoncini E; Zambonin L; Rizzo B; Calabria D; Simoni P; Mirasoli M; Guardigli M; Hrelia S; Roda A; Cicero AFG
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):552-563. PubMed ID: 28511903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of Phyllanthus amarus Schum. & Thonn. through inhibition of NF-κB, MAPK, and PI3K-Akt signaling pathways in LPS-induced human macrophages.
    Harikrishnan H; Jantan I; Haque MA; Kumolosasi E
    BMC Complement Altern Med; 2018 Jul; 18(1):224. PubMed ID: 30045725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia/reperfusion-induced lesion through modulation of HMGB1/TLR4/NF-κB signaling and autophagy.
    Gendy AM; Elnagar MR; Allam MM; Mousa MR; Khodir AE; El-Haddad AE; Elnahas OS; Fayez SM; El-Mancy SS
    Biomed Pharmacother; 2022 Jan; 145():112122. PubMed ID: 34489150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.